HER2-Positive Metastatic Breast Cancer: Current Status and Promising Agents on the Horizon

Review the latest data and expert guidance to enhance treatment of your patients with HER2-positive MBC! This comprehensive program features a text-based educational module with downloadable slides and focused clinical commentaries on recent advances and emerging research.

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Daiichi Sankyo, Inc.

Puma Biotechnology, Inc.

Seagen